POTS Syndrome SSDI in 2026: How Social Security Decides Postural Orthostatic Tachycardia Claims Without a Listing, the Tilt Table Test That Anchors Every File, and the Equivalence Path to Listings 4.05 and 11.14
About 3 million Americans live with Postural Orthostatic Tachycardia Syndrome. Roughly 80 percent of POTS patients are women, most between ages 15 and 50. The number tripled after the COVID-19 pandemic, with post-viral POTS now the single largest subtype. Google Trends interest in POTS hit a sustained peak of 51 over the past 90 days, and the search volume keeps climbing because diagnoses are catching up to the actual prevalence.
Most POTS patients have never heard of SSDI when they first get diagnosed, and most SSA disability examiners have never heard of POTS. That mismatch produces high denial rates and long appeals. The condition is real, the science is settled, and there is a clear path through the SSDI rules. There is just no Blue Book listing for POTS, which means equivalence to a listed condition or an RFC assessment at step 5 is the only way through.
This guide is the long form walkthrough. We cover what POTS is and is not, the diagnostic criteria SSA accepts, the tilt table test results that anchor every winning file, the equivalence path to Listing 4.05 recurrent arrhythmias and Listing 11.14 peripheral neuropathy, the long COVID overlap and what that means for onset and durational requirements, the comorbid conditions that strengthen claims (Ehlers-Danlos, mast cell activation, ME/CFS, autoimmune disease), and the RFC limits that move cases from denial to approval.
POTS claim denied or stuck in appeal? A 2 minute screen will tell you which equivalence path and RFC limits your records actually support.
See If You QualifyWhat POTS is in clinical terms
POTS is a form of dysautonomia, which means dysfunction of the autonomic nervous system. The autonomic system controls heart rate, blood pressure, digestion, and sweating without conscious thought. In POTS, the system fails to regulate heart rate properly when the body moves from lying down to standing up. The result is a heart rate jump of 30 beats per minute or more within 10 minutes of standing (40 bpm or more in patients age 12 to 19), often accompanied by lightheadedness, palpitations, fatigue, brain fog, exercise intolerance, and sometimes syncope.
The diagnosis is clinical and confirmed by autonomic function testing. The tilt table test is the gold standard. The patient lies on a table that tilts to a 60 to 70 degree upright position. Continuous heart rate and blood pressure monitoring during the tilt captures the diagnostic heart rate response. A heart rate jump of 30 bpm or more within 10 minutes of tilt without a corresponding 20/10 mmHg blood pressure drop confirms POTS and rules out orthostatic hypotension.
POTS has at least four recognized subtypes. Neuropathic POTS involves selective denervation of the lower extremities. Hyperadrenergic POTS shows high upright norepinephrine and often a blood pressure rise with standing. Hypovolemic POTS shows low blood volume on testing. Post-viral or post-infectious POTS, including long COVID POTS, often follows an acute illness and may resolve over months to years or persist indefinitely.
POTS commonly travels with other conditions. Ehlers-Danlos Syndrome (especially the hypermobile type, hEDS) is present in about 18 percent of POTS patients. Mast Cell Activation Syndrome (MCAS) is present in another large fraction. Chronic fatigue syndrome (ME/CFS), autoimmune disease (especially Sjogren's and lupus), and small fiber neuropathy all overlap with POTS in ways that strengthen disability claims.
Why POTS has no listing and what SSA actually evaluates
The Blue Book has listings for chronic heart failure, recurrent arrhythmias, ischemic heart disease, and peripheral arterial disease. None of these match POTS. SSA's Section 4.00 cardiovascular preamble does not even mention dysautonomia. The lack of a listing means POTS claims go through medical equivalence under 20 CFR 404.1526 or through an RFC assessment at step 5.
The two most useful equivalence targets are Listing 4.05 recurrent arrhythmias and Listing 11.14 peripheral neuropathy. We cover each below.
Listing 4.05 recurrent arrhythmias requires uncontrolled, recurrent episodes of cardiac syncope or near syncope despite prescribed treatment, occurring at least three times within a 12 month period, documented by Holter monitoring or other appropriate medically acceptable testing, coincident with the occurrence of syncope or near syncope. POTS syncope and near syncope episodes captured on Holter or implanted loop recorder, with the tachycardia clearly contributing, can equal this listing.
Listing 11.14 peripheral neuropathy requires either disorganization of motor function in two extremities resulting in extreme limitation in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities (paragraph A), or marked limitation in physical functioning and one of four areas of mental functioning (paragraph B). The neuropathic subtype of POTS has documented small fiber neuropathy on skin biopsy in many cases, which puts it inside the conceptual territory of 11.14 even if the exact motor disorganization criterion is not met.
For cases that do not equal a listing, the analysis moves to step 4 (can you do past work) and step 5 (can you do other work). RFC is where most POTS cases are decided. We cover that in detail below.
The diagnostic evidence SSA wants to see
A POTS file that survives DDS scrutiny includes specific clinical documentation. The most important pieces are these.
Tilt table test results. The single most important document in the file. The report should include the patient's resting supine heart rate, the heart rate within 10 minutes of tilt, the blood pressure trajectory, any syncope or near syncope event during the test, and the interpretation by the autonomic specialist. A heart rate jump of 30 bpm or more in adults (40 bpm in adolescents) confirms POTS by Heart Rhythm Society 2015 criteria.
Active stand test. The simpler bedside alternative to tilt. The patient's heart rate and blood pressure are measured supine and then at 1, 3, 5, and 10 minutes of standing. Active stand results are accepted by SSA when tilt is not available.
QSART or autonomic reflex screen. Quantitative Sudomotor Axon Reflex Test measures small fiber autonomic function. Abnormal QSART in lower extremities supports the neuropathic POTS subtype and bolsters the 11.14 equivalence argument.
Skin biopsy for small fiber neuropathy. A punch biopsy from the distal leg quantifies epidermal nerve fiber density. Reduced density confirms small fiber neuropathy, which adds neurological evidence and overlaps Listing 11.14.
Holter monitor or implanted loop recorder. A 30 day Zio patch or implanted loop recorder captures the tachycardia during the patient's normal daily activity. Documented heart rates over 120 sustained for 20 minutes or more, recurring throughout the day, are powerful evidence.
Echocardiogram. Used to rule out structural heart disease and to document any deconditioning effects. A normal echo plus high upright heart rate confirms that the problem is autonomic rather than structural.
Plasma norepinephrine. Supine and upright measurements. Raised upright norepinephrine over 600 pg/mL classifies the patient as hyperadrenergic POTS.
Treatment response documentation. SSA gives weight to the failure of standard treatment. Document trials of fludrocortisone, midodrine, beta blockers (propranolol, metoprolol), ivabradine, pyridostigmine, and IV saline infusions. A patient who has tried and failed multiple medications has a stronger case than one who has not been adequately treated.
Walking through the five steps for a POTS claim
Step 1 is SGA. In 2026 the non-blind SGA limit is $1,690 per month. Many POTS patients attempt part-time work below SGA. Earnings below the cap leave the door open to proceed.
Step 2 is severity. POTS as a documented medically determinable impairment with the tilt table evidence above easily meets the severe impairment threshold. The 12 month duration requirement is met in nearly every case because POTS by clinical definition lasts months to years.
Step 3 is the listings. POTS does not meet any listing directly. Equivalence to 4.05 or 11.14 is possible but rare on initial review. Most cases proceed to step 4.
Step 4 is past relevant work. POTS limits include inability to stand or sit upright for prolonged periods without symptom flare, exercise intolerance, brain fog limiting cognitive tasks, and unpredictable syncope or near syncope. If past work required standing, walking, or sustained concentration, the RFC closes off past work.
Step 5 is other work in the national economy. The Grid Rules direct approval for older claimants with limited education and unskilled past work who are restricted to sedentary or less. Younger claimants restricted to less than sedentary, or sedentary with absenteeism and off task time limits, also get approved.
RFC limits that win POTS cases
The most useful RFC limits to document in a POTS case are these.
Standing tolerance. POTS patients often cannot stand more than 5 to 15 minutes without symptom flare. Sedentary work permits up to 2 hours standing per day, but POTS standing tolerance often makes even this impossible. Documented standing tolerance under 30 minutes total per day puts the claimant below sedentary.
Sitting tolerance with upright posture. Sitting fully upright at a desk produces similar autonomic strain in many POTS patients. Reclined or semi-reclined sitting is often the only tolerable posture. Vocational experts uniformly testify that a job requiring reclined posture does not exist at unskilled sedentary level.
Lifting. Most POTS patients lose lifting tolerance due to deconditioning and exercise intolerance. A 5 to 10 pound limit is typical.
Heat intolerance. POTS patients flare in heat. Vocational testimony confirms that no jobs allow strict environmental temperature control under 72 degrees Fahrenheit.
Off task time. POTS brain fog and recurrent near syncope produce significant off task time. Vocational experts uniformly testify that more than 10 percent off task time is work preclusive. A treating cardiologist or autonomic specialist statement quantifying off task time at 15 to 25 percent anchors a step 5 win.
Absenteeism. POTS flares cause unpredictable bad days. Two or more days per month of absenteeism is work preclusive per most VEs. POTS files with documented ER visits or doctor visits for flares support this limit.
Brain fog cognitive limits. POTS commonly causes documented short term memory deficits, processing speed reduction, and sustained attention problems. Neuropsychological testing showing cognitive impairment in the absence of structural brain disease supports a non-exertional limit to simple, routine tasks.
Long COVID POTS: the post-2020 wave
Post-COVID POTS is now the largest single subtype. About 30 percent of long COVID patients meet POTS criteria. SSA has issued internal guidance treating long COVID as a medically determinable impairment when documented by a qualified clinician. The agency does not require a specific COVID test, but does require clinical evidence of POTS-consistent symptoms following the acute infection.
For onset date purposes, long COVID POTS claims often anchor onset to the acute COVID infection date when symptoms began. The 12 month durational requirement starts running from there. Claimants who became disabled within the last year may need to wait for the durational period to mature, or file with a protective filing date and provide updated evidence as the durational period closes.
For more on the long COVID disability framework, see our long COVID disability benefits guide.
The conditions that often travel with POTS and what they add
POTS rarely appears in isolation. Common comorbidities and their impact on disability claims include these.
Ehlers-Danlos Syndrome (hypermobile type, hEDS). Joint hypermobility, chronic musculoskeletal pain, and connective tissue fragility. About 18 percent of POTS patients have hEDS. Adds chronic pain limitations and supports a less than sedentary RFC.
Mast Cell Activation Syndrome (MCAS). Recurrent allergic-type symptoms, GI distress, flushing, and hives. Documented by tryptase, prostaglandin, and histamine testing. Strengthens the symptom-related limits and may support equivalence to immune system disorders under 14.07.
Chronic Fatigue Syndrome (ME/CFS). SSR 14-1p governs ME/CFS evaluation. Many POTS patients meet ME/CFS criteria. The two diagnoses stack to support a stronger fatigue and post-exertional malaise narrative. See our ME/CFS disability guide.
Small Fiber Neuropathy. Confirmed by skin biopsy. Supports equivalence to Listing 11.14 peripheral neuropathy.
Autoimmune disease. Sjogren's syndrome, systemic lupus erythematosus, and other autoimmune diseases have documented associations with POTS. See our Listing 14.02 SLE deep dive.
Two worked examples
Example 1: Sarah in Texas, post-COVID POTS
Sarah is 28, a registered nurse in Austin. She caught COVID in early 2023 and had a typical acute illness with two weeks of fever and respiratory symptoms. By April 2023 she developed lightheadedness on standing, tachycardia, brain fog, and crushing fatigue. Her PCP referred her to cardiology, which ordered a tilt table test in August 2023. The tilt showed a heart rate jump from 78 supine to 132 within 8 minutes upright, with near syncope at the 10 minute mark. POTS confirmed.
Over the next two years Sarah tried fludrocortisone, midodrine, propranolol, ivabradine, IV saline, and compression garments. Symptoms persisted. She attempted to return to part-time nursing work in late 2024 and failed within 8 weeks due to inability to stand for sustained periods and recurring near syncope on the floor. She filed for SSDI in February 2025 with onset April 2023.
Texas DDS denied at initial in August 2025, stating the impairment was severe but did not meet or equal a listing and that her RFC allowed sedentary work. Reconsideration denial in January 2026 maintained the position. At the ALJ hearing in June 2026, her attorney presented a treating autonomic specialist statement quantifying off task time at 20 percent due to brain fog and near syncope, absenteeism at 3 days per month, sitting tolerance upright at 30 minutes before needing to recline, and an inability to work in environments above 72 degrees Fahrenheit. The VE testified that no jobs exist at that combination of limits. The ALJ approved with onset April 2023.
For Texas claimants and the local field office process, see our Texas state page.
Example 2: Marcus in New York, hyperadrenergic POTS with EDS
Marcus is 35, formerly a software engineer in Brooklyn. He has a 10 year history of joint hypermobility, frequent dislocations of the shoulder and patella, and chronic widespread pain. In 2024 he was formally diagnosed with hEDS via Beighton score and genetics consultation. The cardiologist who evaluated his chronic palpitations ran a tilt table that confirmed POTS with upright norepinephrine at 950 pg/mL (hyperadrenergic subtype). Skin biopsy showed reduced epidermal nerve fiber density consistent with small fiber neuropathy.
Marcus stopped working in early 2025 when he could no longer tolerate sitting upright at a desk for the 6 to 8 hour workday his job required. He filed for SSDI in March 2025 with onset January 2025.
His attorney built the case on two paths. Equivalence to Listing 11.14 paragraph B: marked limitation in physical functioning (documented chronic pain, joint dislocations, autonomic dysfunction) plus marked limitation in concentrating, persisting, or maintaining pace (documented brain fog and neuropsychological testing). RFC: less than sedentary because he could not sit upright more than 30 minutes, could not lift more than 5 pounds, had off task time of 25 percent, and absenteeism of 3 days per month.
NY DDS approved at reconsideration in October 2025 on the RFC theory, with onset back to January 2025. For New York claimants, see our New York state page.
Related deep dives on our site
- Long COVID disability benefits 2026 for the post-viral overlap.
- Chronic fatigue syndrome SSDI for the ME/CFS overlap and SSR 14-1p framework.
- SSR 12-2p fibromyalgia evaluation for the parallel ruling for syndrome diagnoses without a listing.
- Listing 14.02 SLE for the autoimmune overlap.
- Listing 4.02 chronic heart failure for the closest cardiovascular listing structure.
- CRPS under SSR 03-2p for another no-listing syndrome that uses the same equivalence framework.
FAQ: POTS Syndrome SSDI claims in 2026
Q1: Does POTS qualify for SSDI automatically?
No. There is no Blue Book listing for POTS. Claims are evaluated through medical equivalence to Listing 4.05 recurrent arrhythmias or Listing 11.14 peripheral neuropathy, or through an RFC assessment at step 5. Most approvals happen at step 5.
Q2: What test does SSA accept to confirm POTS?
The tilt table test is the gold standard. A heart rate jump of 30 bpm or more within 10 minutes of tilt (40 bpm or more for adolescents) without orthostatic hypotension confirms POTS. Active stand test is accepted when tilt is not available. QSART, autonomic reflex screen, skin biopsy, and Holter monitoring strengthen the file.
Q3: How does long COVID POTS affect a disability claim?
Post-COVID POTS is recognized by SSA as a medically determinable impairment when documented by tilt table or active stand testing. Onset date is usually anchored to the acute COVID infection when symptoms began. The 12 month durational requirement runs from there.
Q4: What RFC limits win POTS cases?
Standing under 30 minutes total per day, sitting upright under 30 minutes before needing to recline, lifting under 10 pounds, off task time over 10 percent, absenteeism over one day per month, and environmental temperature restrictions. Brain fog cognitive limits supporting simple, routine tasks add a non-exertional layer.
Q5: Does EDS or MCAS make a POTS claim stronger?
Yes. Comorbid Ehlers-Danlos Syndrome, Mast Cell Activation Syndrome, ME/CFS, small fiber neuropathy, and autoimmune disease all add corroborating evidence and additional functional limits. Comorbid hEDS adds chronic pain and joint instability. Small fiber neuropathy adds an equivalence pathway to Listing 11.14.
Q6: How long does a POTS SSDI claim take in 2026?
Initial decision averages 199 days nationally. Reconsideration adds about 110 days. ALJ hearings average 280 days from request to decision after the 2026 backlog reduction. Most POTS cases reach a hearing.
Q7: Can children get SSI for POTS?
Yes, under the childhood disability standard. For children age 12 to 19, the diagnostic heart rate criterion is 40 bpm or more on tilt. Functional equivalence to a listing or marked or extreme limitation in domains of functioning under 416.926a applies. See our childhood disability guide for the framework.
Ready to find out where your POTS claim stands? The screen takes 2 minutes and we will tell you which equivalence path or RFC limits your records support.
See If You Qualify